Group B Streptococcus Infection and PROM Incidince

NCT06735703 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-12-16

No results posted yet for this study

Summary

To investigate incidince of prom with GBS infection and role of prophylaxis against it

Conditions

  • Premature Rupture of Fetal Membranes
  • Group B Streptococcal Infection

Interventions

DRUG

To provide ampicillin sulbactam to pregnant women with premature rupture of membrane

To provide ampicillin sulbactam tonpregnant women with premature rupture of membrane after 34 wks gestation

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-25
Primary Completion
2025-12-09
Completion
2026-01-09

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06735703 on ClinicalTrials.gov